DDMAC says promo pieces were Rythmol SR were misleading

Share this article:
DDMAC says two promotional pieces for Reliant Pharmaceuticals' Rythmol SR were false or misleading because they failed to include any risk information and they broadened the indication for the product. A corrective message campaign was requested.
Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.